Follow


Submissions from 2019

Link

Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agents., Jehad Almaliti, Bailey Miller, Halina Pietraszkiewicz, Evgenia Glukhov, C Benjamin Naman, Toni Kline, Jeffrey Hanson, Xiaofan Li, Sihong Zhou, Frederick A Valeriote, and William H Gerwick

Link

Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis., Jesus G Berdeja, Michael C Heinrich, Shaker R Dakhil, Stuart L Goldberg, Martha Wadleigh, Philip Kuriakose, Jorge Cortes, Jerald Radich, Bret Helton, David Rizzieri, Carole Paley, Ilva Dautaj, and Michael J Mauro

Link

Highly Convergent Total Synthesis and Assignment of Absolute Configuration of Majusculamide D, a Potent and Selective Cytotoxic Metabolite from Moorea sp., Eduardo J E Caro-Diaz, Frederick A Valeriote, and William H Gerwick

Link

A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment., Meredith C Henderson, Michael Silver, Quynh Tran, Elias E Letsios, Rao Mulpuri, David E Reese, Ana P Lourenco, Joshua LaBaer, Karen S Anderson, Josie Alpers, Carrie Costantini, Nitin Rohatgi, Haythem Ali, Karen Baker, Donald W Northfelt, Karthik Ghosh, Stephen R Grobmyer, Winnie Polen, and Judith K Wolf

Link

Evaluation of a Multidisciplinary Team Approach for Generating Survivorship Care Plan Treatment Summaries in Patients With Breast Cancer., Tommy Ivanics, Erica Proctor, Yalei Chen, Haythem Y Ali, Dawn Severson, Hassan Nasser, Sonja Colbert, Laura L. Susick, Eleanor Walker, Lindsay Petersen, Jessica Bensenhaver, Randa Loutfi, S David Nathanson, and Lisa A Newman

Link

Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry, Brittany D Jenkins, Rachel N Martini, Rupali Hire, Andrea Brown, Briana Bennett, I'nasia Brown, Elizabeth W Howerth, Mary Egan, Jamie Hodgson, Clayton Yates, Rick Kittles, Dhananjay A Chitale, Haythem Y Ali, S David Nathanson, Petros Nikolinakos, Lisa A Newman, Michele Monteil, and Melissa B Davis

Link

Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors., Matthew Lei, Angela Michael, Seema Patel, and Ding Wang

Link

US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials., Jeanne M Regnante, Nicole A Richie, Lola Fashoyin-Aje, Michelle Vichnin, Marvella Ford, Upal Basu Roy, Kenneth Turner, Laura Lee Hall, Evelyn Gonzalez, Nestor Esnaola, Luther T Clark, Homer C Adams, Olatunji B Alese, Keerthi Gogineni, Lorna McNeill, Daniel Petereit, Ify Sargeant, Julie Dang, Coleman Obasaju, Quita Highsmith, Simon Craddock Lee, Spencer C Hoover, Erin L Williams, and Moon S Chen

Link

Colorectal Cancer and Nutrition., Kannan Thanikachalam and Gazala Khan

Link

Development of an algorithm for the systematic evaluation of patients with suspected heparin-induced thrombocytopenia., Julie Thomson, Philip Kuriakose, Long To, Michael Peters, and James Kalus

Link

Computationally Assisted Discovery and Assignment of a Highly Strained and PANC-1 Selective Alkaloid from Alaska's Deep Ocean., Yike Zou, Xiaojuan Wang, James Sims, Bin Wang, Pankaj Pandey, Colin L Welsh, Robert P Stone, Mitchell A Avery, Robert J Doerksen, Daneel Ferreira, Clemens Anklin, Frederick A Valeriote, Michelle Kelly, and Mark T Hamann

Submissions from 2018

Link

Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer., Jessica L Christenson, Jane B Trepel, Haythem Y Ali, Sunmin Lee, Joel R Eisner, Edwina S Baskin-Bey, Anthony D Elias, and Jennifer K Richer